Abbott, WARF Hit Anchen With Zemplar Patent Suit

Law360, New York (October 26, 2010, 3:23 PM EDT) -- Abbott Laboratories and the Wisconsin Alumni Research Foundation have slapped Anchen Pharmaceuticals Inc. with a patent infringement suit over the generic-drug maker's efforts to introduce its own version of kidney disease drug Zemplar.

Morris Nichols Arsht & Tunnell LLP's Mary B. Graham lodged the suit on behalf of Abbott and WARF in the U.S. District Court for the District of Delaware on Monday, accusing Anchen of infringing U.S. Patent Number 5,587,497.

The suit comes after Anchen filed an abbreviated new drug application with the U.S. Food...
To view the full article, register now.